Credits

Il presente sito è di proprietà di Ipsen S.p.A.

I contenuti di questo sito sono stati redatti grazie alla consulenza scientifica dei rappresentanti di

L'iniziativa ha inoltre ricevuto il patrocinio di ISA: Italian Stroke Association, RITB - Rete Italiana Tossina Botulinica, SIMFER - Società Italiana di Medicina Fisica e Riabilitativa, SIN - Società Italiana di Neurologia, SIRN - Società Italiana di Riabilitazione Neurologica, A.I.FI. Associazione Italiana di Fisioterapia e A.L.I.Ce. Italia Odv.

Bibliografia

Per la pagina “Spasticità post-ictus”:

Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke Neurology. 2013 Jan 15;80(3 Suppl 2):S20-6. doi: 10.1212/WNL.0b013e31827624a7. PMID: 23319482.
SPREAD – Stroke Prevention and Educational Awareness Diffusion Ictus cerebrale: Linee guida italiane di prevenzione e trattamento Raccomandazioni e Sintesi VIII edizione. 2016. http://iso-spread.it/index.php
Spasticity in adults: management using botulinum toxin National guidelines. London, RCP, 2018

Per la pagina “Percorso di cura”:

Giannotti E, Merlo A, Zerbinati P, Longhi M, Prati P, Masiero S, Mazzoli D. Early rehabilitation treatment combined with equinovarus foot deformity surgical correction in stroke patients: safety and changes in gait parameters. Eur J Phys Rehabil Med. 2016 Jun;52(3):296-303.
Rosales RL, Efendy F, Teleg ES, Delos Santos MM, Rosales MC, Ostrea M, Tanglao MJ, Ng AR. Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci. 2016 Dec 15;371:6-14. doi: 10.1016/j.jns.2016.10.005.
Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M, Daniele A, Picelli A, Baricich A, Intiso D, Ranieri M. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. Drugs. 2019 Feb;79(2):143-160. doi: 10.1007/s40265-018-1042-z.
Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment Brain Inj. 2013;27(10):1093-105. doi: 10.3109/02699052.2013.804202. Epub 2013 Jul 25. PMID: 23885710.
Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III). BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen
Wissel J, Verrier M, Simpson DM, Charles D, Guinto P, Papapetropoulos S, Sunnerhagen KS. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PM R. 2015 Jan;7(1):60-7. doi: 10.1016/j.pmrj.2014.08.946. Epub 2014 Aug 27. PMID: 25171879.

Per la pagina “Terapie”:

Baricich A, Picelli A, Carda S, Smania N, Cisari C, Santamato A, de Sire A, Invernizzi M. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study. Ann Phys Rehabil Med. 2019 Jul;62(4):214-219. doi: 10.1016/j.rehab.2019.06.002.
Creamer M, Cloud G, Kossmehl P, Yochelson M, Francisco GE, Ward AB, Wissel J, Zampolini M, Abouihia A, Berthuy N, Calabrese A, Loven M, Saltuari L. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):642-650. doi: 10.1136/jnnp-2017-317021
Foresti C., Ubiali E., Usi clinici della tossina botulinica. Il trattamento della spasticità con tossina botulinica, Scienza Medica, Torino, 2004
Nair KP, Marsden J. The management of spasticity in adults. BMJ. 2014 Aug. 5;349:g4737. doi: 10.1136/bmj.g4737. PMID: 25096594
Picelli A, Santamato A, Chemello E, Cinone N, Cisari C, Gandolfi M, Ranieri M, Smania N, Baricich A. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature. Ann Phys Rehabil Med. 2019 Jul;62(4):291-296. doi: 10.1016/j.rehab.2018.08.004.
Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009 Jan;41(1):13-25. doi: 10.2340/16501977-0303